Does immune dysfunction contribute to schizophrenia?

Key points
- A new study reinforces the finding that a region of the genome involved in immune system function, called the major histocompatibility complex (MHC), is involved in the genetic susceptibility to schizophrenia.
- Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior.
- Elsevier is a world-leading provider of scientific, technical and medical information products and services.
- Schizophrenia is among the most disabling psychiatric disorders.
A new study reinforces the finding that a region of the genome involved in immune system function, called the major histocompatibility complex (MHC), is involved in the genetic susceptibility to schizophrenia.
Schizophrenia is among the most disabling psychiatric disorders. Approximately 80% of the risk for developing schizophrenia is heritable, but there has been slow progress in identifying genetic variation that contributes to the risk for schizophrenia.
The current paper contributes to this growing literature by identifying variants of genes that influence the function of the immune system which may contribute to the heritable risk for schizophrenia.
Two large, international, collaborating groups of scientists – the Wellcome Trust Case Control Consortium 2 and the Irish Schizophrenia Genomics Consortium – conducted this new study.
They first performed what is called a discovery scan, where they analyzed over 6 million genetic variants in schizophrenia patients and controls from Ireland. This allowed them to compile a list of variants that showed the strongest association signals with schizophrenia.
They then performed similar work in an independent sample of 13,195 cases and 31,021 controls from around the world in order to search for the same top 'hits'. This wealth of data was provided by the international schizophrenia genetics community. This replication work is an important scientific strategy, particularly in the field of genetics, to strengthen and support the original findings.
Using these multiple datasets and approaches, their findings lend further support for the involvement of the MHC genes in schizophrenia susceptibility. "In this large collaborative effort, we have replicated evidence for specific risk and protective alleles at the MHC locus - a critical step teasing apart the genetic risk mechanisms involved," commented Dr. Aiden Corvin, one of the lead authors and a professor at Trinity College Dublin. "However, pinpointing specific risk genes or alleles has been challenging because this is a region of great genomic variation within and between populations."
These genetic findings also highlight an important gap in our understanding of the biology of schizophrenia. There is a long history of interest in immunologic contribution to schizophrenia including wide ranging observations linking viral infection, gluten sensitivity, changes in cytokine levels in blood and cerebrospinal fluid, and other factors to schizophrenia.
"Despite this, we have relatively little understanding how alterations in immune function are involved in the etiology and pathophysiology of this disorder," commented Dr. John Krystal, Editor of Biological Psychiatry. "Immunologic studies in schizophrenia that illuminate the nature of the contribution of variation in immune system genes to schizophrenia will be an important new direction in schizophrenia research."###
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →
NewsDirect Current Stimulation Boosts Cognition in Schizophrenia
Transcranial direct current stimulation (tDCS) may improve short-term memory in people with schizophrenia, a small study suggests. Cognitive impairment is nearly ubiquitous in patients with schizophrenia, and effective…
6 June 2015
NewsInjection Drug Shows Prolonged Effectiveness in Schizophrenia
Monthly injections of paliperidone palmitate showed prolonged efficacy compared with daily oral antipsychotics in a new trial involving a group of schizophrenia patients who rarely participate in clinical research. "A…
4 June 2015
NewsScientists produce strongest evidence yet of schizophrenia's causes
An international team of scientists led by Cardiff University researchers has provided the strongest evidence yet of what causes schizophrenia - a condition that affects around 1% of the global population. Published…





